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Background: The aim of this study was to investigate the neuroprotective effects of sevoflurane after severe forebrain 
ischemic injury. We also examined the relationship between the duration of ischemia and neuronal cell death.
Methods: Male Sprague-Dawley rats (300-380 g) were subjected to 6 (each n = 6) or 10 min (each n = 10) of 
near-complete forebrain ischemia while anesthetized with either 50 mg/kg of zoletil given intraperitoneally or 
inhaled sevoflurane (2.3%). Ischemia was induced by bilateral common carotid artery occlusion plus hemorrhagic 
hypotension (26-30 mmHg). Histologic outcomes were measured 7 days after ischemia in CA1 pyramidal cells of the 
rat hippocampus.
Results: The mean percentage of necrotic cells in the hippocampal CA1 area decreased in the sevoflurane group 
compared to the zoletil group (25% vs. 40% after 6 min ischemia, respectively: P = 0.004 and 44% vs. 54% after 10 
min of ischemia, respectively P = 0.03). The percentage of apoptotic cells was similar in all groups. The percentage of 
necrotic cells in each anesthetic groups was significantly higher in the 10 min ischemia group compared to the 6 min 
ischemia group (P = 0.004 in the sevoflurane group, P = 0.03 in the zoletil group).
Conclusions: The present data show that sevoflurane has neuroprotective effects in rats subjected to near-complete 
cerebral ischemia. Longer duration of ischemia is associated with more neuronal injury when compared to ischemia 
of shorter duration. (Korean J Anesthesiol 2011; 61: 327-331)
Key Words:  Brain ischemia, Hippocampus, Inhalation anesthetics, Neuron.
Effects of sevoflurane on neuronal cell damage after severe 
cerebral ischemia in rats
Hee-Pyoung Park
1, Eun-Ju Jeong
1, Mi-Hyun Kim
1, Jung-Won Hwang
2, Young-Jin Lim
1, Seong-Won 
Min
3, Chong-Soo Kim
3, and Young-Tae Jeon
2
Department of Anesthesiology and Pain Medicine, 
1Seoul National University Hospital, Seoul, 
2Seoul National University Bundang 
Hospital, Seongnam, 
3Seoul City Boramae Hospital, Seoul, Korea
Received: January 25, 2011.  Revised: May 17, 2011.  Accepted: May 21, 2011.
Corresponding author: Young-Tae Jeon, M.D. Ph.D., Department of Anesthesiology and Pain Medicine, Seoul National University Bundang 
Hospital, 300, Gumi-dong, Bundang-gu, Seongnam 463-802, Korea. Tel: 82-31-787-7493, Fax: 82-31-787-4063, E-mail: ytjeon@snubh.org
    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
CC328 www.ekja.org
Vol. 61, No. 4, October 2011 Sevoflurane and ischemia
Introduction
Numerous studies have demonstrated some degree of 
a neuroprotective effect with isoflurane [1,2], sevoflurane 
[3,4] and desflurane [2,5] after cerebral ischemia. The 
neuroprotective effects of anesthetic agents depend on the 
severity of ischemic injury. During less severe ischemia, 
anesthetic agents (fentanyl, ketamine, and isoflurane) resulted 
in no differences in outcome. In contrast, in animals sustaining 
a severe insult, those that were anesthetized with isoflurane had 
less damage than did rats given either ketamine or fentanyl [6]. 
Zoletil is a combination of a dissociative anesthetic, tileta-
mine hydrochloride, and a benzodiazepine, zolazepam hypo-
chloride. Tiletamine is a noncompetitive antagonist at the 
phencyclidine site of N-methyl-D-aspartate receptor.
Sevoflurane has been shown to provide neuroprotection 
against focal [3] or incomplete global cerebral ischemia [4] 
in rats. To our knowledge, there has been no effort to define 
the effects of sevoflurane against severe forebrain global 
ischemia. The purpose of the present study was to determine 
the neuroprotective effects of sevoflurane on severe forebrain 
ischemic injury. We also examined the relationship between 
ischemic duration and neuronal death. Neuroprotection was 
assessed by histopathological evaluation 7 days after ischemia. 
Degrees of neuronal damage in ischemic hippocampal CA1 
cells were assessed by counting necrotic cells after H&E staining 
and detection of DNA fragmentation was performed by terminal 
deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-
biotin nick end labeling (TUNEL) staining. 
Materials and Methods
The following study was approved by the Institutional 
Animal Care and Use Committee. Male Sprague-Dawley 
rats (300-380 g, 10-16 wks) were fasted 12-16 h before the 
experiments but were allowed free access to water. Rats were 
then randomly assigned to one of 4 conditions based on the 
anesthetics and duration of ischemia. In the 6 (n = 6) or 10 min 
(n = 10) sevoflurane group, the animals were anesthetized with 
5% sevoflurane in oxygen and during surgery, a level of 2.3% 
sevoflurane in 100% O2 was maintained under spontaneous 
breathing. In the 6 (n = 6) or 10 min (n = 10) zoletil group, 50 mg/
kg of zoletil (Virbac, Nice, France) was given intraperitoneally. 
The tail artery was catheterized with a PE-50 catheter to allow 
continuous recording of arterial blood pressure and blood 
sampling. The common carotid arteries were encircled with 
suture. The right jugular vein was cannulated with a silicone 
catheter for drug infusion and blood withdrawal. A 22-gauge 
needle thermistor was percutaneously placed adjacent to 
the skull beneath the temporalis muscle, and pericranial 
temperature was servoregulated (model TCAT-2 Temperature 
Controller; Harvard apparatus, Holliston, MA, USA) at 37.5 ± 
0.1
oC by surface heating or cooling. Heparin (50 U) was given 
intravenously.
Anesthetic conditions were established 30 min before 
ischemia, during which time rats in both groups were allowed to 
stabilize physiologically. Arterial blood gases and hemoglobin 
were measured 10 min before and after ischemia. 
Transient global ischemia was induced by bilateral common 
carotid artery occlusion and bleeding to lower the mean arterial 
pressure (MABP) to 26-30 mmHg using the method originally 
described by Smith et al. [7]. The carotids were then occluded 
with aneurysm clips. After 6 or 10 min of ischemia, the shed 
blood was reinfused. After regaining consciousness, the animals 
were maintained in an air conditioned room at 20
oC. For each 
recovery interval, a set of sham rats was generated (n = 4). These 
animals were exposed to all aspects of sevoflurane anesthesia 
and surgical preparation for ischemia. The carotids were not 
occluded, and systemic hypotension was not used. 
After completion of the ischemic protocol, rats were allowed 
to recover for 7 days. All rats were anesthetized with sevoflurane, 
and the brains were fixed in situ by intraaortic infusion with 
buffered 10% formalin. Paraffin-embedded brain sections were 
serially cut (5 μm thick) and stained with hematoxylin and eosin. 
With the investigator blinded to group assignment, injury to the 
hippocampal CA1 sector was evaluated by microscopy. The total 
number of neurons (viable plus nonviable) was counted for each 
animal. The percentage of necrotic (eosinophilic) CA1 neurons 
was calculated as necrotic neurons/total neurons ×100. In each 
animal, five optical fields of the hippocampal CA1 region were 
examined.
For the detection of DNA fragmentation, TUNEL staining 
was performed with the Apoptag
Ⓡ Peroxidase In Situ Apoptosis 
Detection Kit S7100 (Millipore Corporation, Billerica, USA). 
After deparaffinizing with xylene and graded concentrations 
of alcohol, brain sections were exposed to Proteinase K for 15 
min at room temperature. Endogenous peroxidase activity was 
quenched with 3% hydrogen peroxide in phosphate buffered 
saline (PBS) for 5 min at room temperature. Sections were then 
incubated with terminal deoxynucleotidyl transferase (TdT) 
in a humidified chamber at 37
oC for 1h. After incubation with 
anti-digoxigenin-conjugate for 30 min at room temperature, 
peroxidase substrate (0.05% diaminobenzidine, DAB) was 
applied to develop color. The specimens were then washed with 
distilled water and were counterstained with 0.5% methyl green 
for 10 min at room temperature. TUNEL-positive neurons that 
contained apoptotic bodies were identified as being neurons 
undergoing apoptosis. The number of apoptotic cells was 
counted under high-power microscopic magnification (×400). 
In each animal, five optical fields of the hippocampal CA1 329 www.ekja.org
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region were examined. The percentage of TUNEL-positive cells 
was defined as the percentage of the number of TUNEL-positive 
cells to the total cell number.
The quantitative data were presented as the mean ± SD. 
Physiologic parameters were analyzed by repeated measures 
analysis of variance. Statistical significance between groups 
was analyzed using a Mann-Whitney U test. Differences were 
considered significant when P < 0.05.
Results
Physiologic parameters are summarized in Table 1. There 
were no significant differences in mean arterial pressure, pH, 
PaCO2, PaO2, and hemoglobin concentration between the 
control and the sevoflurane treated groups at any time point.
Of the 20 animals receiving 10 min of ischemia, five rats 
in the zoletil treated group died before the determination of 
neurologic damage. A majority of the postoperative deaths 
occurred within 3 days of ischemia. No animals died after 6 
min of ischemia and no neuronal death was observed in the 
sham-operated group. The mean percentage of necrotic cells 
in the zoletil 6 min group was significantly higher than in the 
sevoflurane 6 min group (Fig. 1: P = 0.004) and similar results 
were seen in the zoletil 10 and sevoflurane 10 group (Fig. 2: 
P = 0.03). The percentage of necrotic cells in each anesthetic 
group was significantly higher in the 10 min ischemia group 
compared to the 6 min ischemia group (Fig. 1, 2: P = 0.004 in the 
sevoflurane group, P = 0.03 in the zoletil group).
Increases in the percentages of TUNEL-positive cells were 
observed in all groups as compared to the sham-operated group 
(P < 0.001). No significant differences in TUNEL-positive cells 
in the CA1 region were observed among the anesthetic groups 
(Fig. 1 and 2). 
Discussion
In the present study, we investigated the neuroprotective 
effect of sevoflurane on near-complete cerebral ischemia. This 
study demonstrated that histologic outcome after 6 or 10 min 
Fig. 1. The percentage of necrotic and apoptotic cells in the hippo-
campus 7 days after forebrain ischemia. The percentage of necrotic 
cells was lower in the sevoflurane 6 min ischemia group (*P < 0.05). 
There is no significant difference between groups with respect to 
apoptotic cell number. All data are expressed as mean ± SD.
Fig. 2. The percentage of necrotic and apoptotic cells in the hippo-
campus 7 days after forebrain ischemia. The percentage of necrotic 
cells was lower in the sevoflurane 10 min ischemia group (*P < 0.05). 
The percentage of necrotic cells in each anesthetic group is higher in 
the 10 min ischemia group compared with the 6 min ischemia group 
(
†P < 0.05). There are no significant differences between groups with 
respect to apoptotic cell numbers. All data are expressed as mean ± SD.
Table 1. Physiological Parameters 10 min before and after Ischemia
pH
PaCO2, 
mmHg
PaO2, 
mmHg
Hemoglobin,  
g/dl
MAP,  
mmHg
Blood glucose  
(mg/dl)
Zoletil 6
Sevoflurane 6  
Zoletil 10
Sevoflurane 10 
Before
After
Before
After
Before
After
Before
After
7.33 ± .04
7.33 ± .02
7.32 ± .05
7.33 ± .03
7.36 ± .03
7.33 ± .02
7.31 ± .03
7.34 ± .04
45 ± 6
40 ± 9
48 ± 10
40 ± 11
43 ± 3
39 ± 3
48 ± 4
48 ± 6
230 ± 38
195 ± 39
250 ± 72
179 ± 21
240 ± 39
220 ± 20
203 ± 46
198 ±37 
12.9 ± 1.9
12.5 ± 1.4
12.8 ± 1.4
11.4 ± 1.4
13.8 ± 1.6
14.0 ± 1.2
14.0 ± 1.2
13.8 ± 0.6
96 ± 30
88 ± 9
92 ± 13
87 ± 8
105 ± 13
116 ± 14
84 ± 12
92 ± 11
91 ± 9
94 ± 10
96 ± 10
92 ± 10
Data are expressed as mean ± SD.330 www.ekja.org
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of severe forebrain ischemia were substantially better in rats 
with sevoflurane versus zoletil anesthesia 7 days after ischemia. 
Sevoflurane did not decrease ischemia-induced apoptotic cell 
death 7 days after ischemia. Shorter duration of ischemia was 
associated with less neuronal damage.
In rats subjected to incomplete cerebral ischemia, sevo-
flurane improved neurologic outcomes [4]. In the present study, 
we focused on the severity of cerebral ischemia. Others have 
shown that there was no effect of anesthetic agents on outcome 
in less severe incomplete ischemia [6]. Cerebral blood flow 
studies after the near-complete insult causing EEG isoelectricity 
have consistently found flow to be severely reduced. In contrast, 
examination of cerebral blood flow during less severe forebrain 
injury found substantial scatter in the magnitude of cerebral 
blood flow reduction [8]. The near-complete ischemia insult 
was uniformly severe across all animals. In contrast, findings 
in the incomplete model varied with respect to concordance 
between cortical and hippocampal regions as well as between 
the presence or absence of EEG activity [6]. In the current study, 
sevoflurane showed better histologic outcomes in rats subjected 
to severe cerebral ischemia. Six min of ischemia also induced 
severe neuronal injury. In contrast to our study, a previous 
study showed sevoflurane completely prevented the neuronal 
eosinophilic damage (a valid indicator of necrosis) of the brain 
in incomplete cerebral ischemia [9]. The neuroprotective effect 
of anesthetic agents seems to be correlated with the severity 
of neurologic injury. Anesthetic agents provide sustained 
neuroprotection in the presence of less severe ischemic states 
[9,10]. In contrast, in a rat focal ischemia model, isoflurane 
did not lead to sustained neuroprotection after 14 days [11]. 
This suggests that the severity of cerebral ischemia is beyond 
the neuroprotective potential of anesthetic agents to prevent 
necrotic cell death.
The mechanisms by which volatile anesthetic agents 
potentially protect the brain are still unclear. Cerebral 
protection with sevoflurane has been explained by a reduction 
in cerebral requirements, similar to barbiturates or isoflurane. 
The neuroprotective effects of volatile anesthetic agents are 
associated with decreased apoptotic cell death in the post-
ischemic period [12-15]. Anesthesia with sevoflurane induces 
a sustained inhibition of neuronal injury by promoting anti-
apoptotic pathways [9,16]. It was demonstrated that sevoflurane 
prevents the ischemia-induced increase of the pro-apoptotic 
protein Bax 4 h after injury induced by incomplete cerebral 
ischemia [16]. Sevoflurane increases the hippocampal con-
centration of the anti-apoptotic proteins Bcl-2 and Mdm-
2 in addition to inhibiting the upregulation of Bax [9]. In the 
present study, sevoflurane did not decrease TUNEL positive 
cells. Kawaguchi et al.[13] showed that volatile anesthetics 
delayed but did not prevent neuronal apoptosis after focal 
cerebral ischemia. We propose that any anti-apoptotic effect of 
sevoflurane might disappear 7 days after ischemia. 
In the present study, shorter durations of ischemia had 
significantly less damage than longer durations (i.e. 6 vs 10 min). 
Consistent with our study, the magnitude of ischemic injury is 
dependent on the duration of ischemia [17]. Sevoflurane did not 
prevent neuronal damage following ischemia of 6 min duration. 
We speculate that even short durations of severe hypotension 
can cause severe damage which cannot be prevented by 
sevoflurane. 
We used 2.3 vol% sevoflurane for maintenance of anesthesia. 
One minimal alveolar concentration of sevoflurane is 2.3 vol% 
in adult rats [18]. Therefore, the sevoflurane concentration used 
in this study was relevant.
There are several limitations in this study. First, the study was 
limited to 7 days after ischemia. Longer periods of time may 
be necessary to assess the permanent neuroprotective effect of 
anesthetics. However, maintaining rats for such a long period 
of time after cerebral ischemia is not feasible in our laboratory. 
Second, we did not confirm EEG isoelectricity. However, it 
is well demonstrated that bilateral common carotid artery 
occlusion plus hemorrhage (30 mmHg) induces near-complete 
ischemia in the CA1 region of rats [6,19]. Third, we classified 
necrosis and apoptosis. Attempts to classify CA1 neuronal 
death as either necrosis or apoptosis may be misleading when 
attempting to understand mechanisms of death of differentiated 
neurons. These neurons might possess some of the phenotypic 
characteristics of necrotic neurons but, in contrast, possess all 
of the biochemical and molecular characteristics needed to die 
via apoptosis.
In summary, this study shows that sevoflurane improves 
neurological outcome after severe cerebral ischemia in rats 
compared with animals anesthetized with zoletil. Longer 
duration of cerebral ischemia is associated with more neuronal 
damage than shorter durations of ischemia.
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